Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma

Authors

Parvin F. Peddi, Washington University School of Medicine in St. Louis
May Cho, Washington University School of Medicine in St. Louis
Jian Wang, Zhengzhou University
Feng Gao, Washington University School of Medicine in St. LouisFollow
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis

Journal

Journal of Gastrointestinal Oncology

Publication Date

2013

Volume

4

Issue

4

Inclusive Pages

370-373

Document Type

Open Access Publication

DOI

10.3978/j.issn.2078-6891.2013.034

Rights and Permissions

Peddi PF, Cho M, Wang J, Gao F, Wang-Gillam A. Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma. J Gastrointest Oncol 2013;4(4):370-373. doi: 10.3978/j.issn.2078-6891.2013.034

Recommended Citation

Peddi, Parvin F.; Cho, May; Wang, Jian; Gao, Feng; and Wang-Gillam, Andrea, "Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma." Journal of Gastrointestinal Oncology. 4, 4. 370-373. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1960